Watch this space! Congratulations to our outstanding client, Faeth Therapeutics, on their Series A and emergence into prime time!
| less than a minute read
Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions
Get in touch
Get in touch
The goal is to transform cancer treatment with nutrition and make it the fourth “pillar” in the oncology regimen, which to date has centered on radiotherapy, surgery and drugs, Faeth CEO Anand Parikh told Endpoints News.
Get in touch
Get in touch
Latest Insights
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-15-32-04-091-6a7205f4b4306b41266d92f2.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-18-23-13-222-6a722e11663e81e26a6b2c3e.jpg)
